Artículos por temáticas

The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy.

Choi JY, Kim SK, Park ES.

Toxins (Basel). 2019 Nov 8;11(11). pii: E651. doi: 10.3390/toxins11110651.

Clinical understanding of spasticity: implications for practice.

Bhimani R, Anderson L.

Rehabil Res Pract. 2014;2014:279175. doi: 10.1155/2014/279175.

Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.

Charles PD, Gill CE, Taylor HM, Putman MS, Blair CR, Roberts AG, Ayers GD, Konrad PE.

Mov Disord. 2010 Mar 15;25(4):466-73. doi: 10.1002/mds.22995.

Surgical Treatment of Pediatric Upper Limb Spasticity: The Shoulder.

Seruya M, Johnson JD.

Semin Plast Surg. 2016 Feb;30(1):45-50. doi: 10.1055/s-0035-1571253.

Guideline for Botulinum Toxin Injections in the Effective Treatment of Fibular Spasticity

Choi YJ, Cho TH, Won SY, Yang HM.

Clin Anat. 2020 Apr;33(3):365-369. doi: 10.1002/ca.23487. Epub 2019 Oct 18.

Budget Impact Analysis Of Botulinum Toxin A Therapy For Upper Limb Spasticity In Germany.

Zoellner YF, Gerwe M, Richter M.

Value Health. 2014 Nov;17(7):A479-80. doi: 10.1016/j.jval.2014.08.1386. No abstract available.

Intrathecal baclofen therapy for spasticity of cerebral origin--does the position of the intrathecal catheter matter?

Sivakumar G, Yap Y, Tsegaye M, Vloeberghs M.

Childs Nerv Syst. 2010 Aug;26(8):1097-102. doi: 10.1007/s00381-010-1124-z.

Decreased spasticity in primary lateral sclerosis after botulinum toxin injection: A case report.

Alabajos Cea A, Máñez Añón I, Roda Alcayde C, Vázquez Costa JF, Guevara Salazar M.

Neurologia. 2016 Mar 8. pii: S0213-4853(16)00051-7. doi: 10.1016/j.nrl.2016.01.005. [Epub ahead of print] English, Spanish. No abstract available.

Prevalence of unmet needs for spasticity management in care home residents in the East Midlands, United Kingdom: a cross-sectional observational study.

Edwards L, Ellis B, Donnellan C, Osman H, Haboubi N, Jones M, Sunman W, Pinnington L, Phillips MF.

Clin Rehabil. 2019 Jul 2:269215519859621. doi: 10.1177/0269215519859621. [Epub ahead of print]

Effect of repetitive transcranial magnetic stimulation on reducing spasticity in patients suffering from HTLV-1-associated myelopathy.

Amiri M, Nafissi S, Jamal-Omidi S, Amiri M, Fatehi F.

J Clin Neurophysiol. 2014 Dec;31(6):547-51. doi: 10.1097/WNP.0000000000000102.

F-wave characteristics as surrogate markers of spasticity in patients with secondary progressive multiple sclerosis.

Argyriou AA, Karanasios P, Makridou A, Makris N.

J Clin Neurophysiol. 2010 Apr;27(2):120-5. doi: 10.1097/WNP.0b013e3181d64c94.

Retraction Note to: Surgical management of intractable spasticity.

Barakat MI, Elhady W, Gouda M, Taha M, Metwaly I.

Eur Spine J. 2016 Aug;25(8):2676. No abstract available.

Application device for THC:CBD oromucosal spray in the management of resistant spasticity: pre-production testing.

Montero-Escribano P, Vila Silván C.

Expert Rev Med Devices. 2019 Sep;16(9):835-840. doi: 10.1080/17434440.2019.1653182. Epub 2019 Aug 19.

Effect of botulinum toxin type-A in patients with focal spasticity.

Selimoglu E, Turgut ST, Akpinar P, Yumusakhuylu Y, Haliloglu S, Baklacioglu HS, Icagasioglu A.

North Clin Istanb. 2015 Jan 24;1(3):153-157. doi: 10.14744/nci.2014.43531.

A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity.

Poorkaj P, Raskind WH, Leverenz JB, Matsushita M, Zabetian CP, Samii A, Kim S, Gazi N, Nutt JG, Wolff J, Yearout D, Greenup JL, Steinbart EJ, Bird TD.

Mov Disord. 2010 Jul 30;25(10):1409-17. doi: 10.1002/mds.23085.